Pre-treatment antibodies to infliximab and adalimumab are common but are not associated with anti-TNF treatment failure

被引：0
|
作者：
Nice, R. [1 ,2 ]
Goodhand, J. R. [2 ,3 ]
Kennedy, N. [2 ,3 ]
Ahmad, T. [2 ]
Winyard, P. [2 ]
McDonald, T. J. [1 ,2 ]
机构：
[1] Royal Devon & Exeter NHS Fdn Trust, Blood Sci, Exeter, Devon, England
[2] Univ Exeter, Med Sch, Exeter, Devon, England
[3] Royal Devon & Exeter NHS Fdn Trust, Gastroenterol, Exeter, Devon, England
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P196
引用
收藏
页码：I256 / I256
页数：1
相关论文
共 50 条
  • [31] Does failure to respond to one anti-TNF agent in Ulcerative Colitis predict treatment failure with other anti-TNF agents?
    AlAlawi, F.
    Keegan, D.
    Byrne, K.
    Mulcahy, H.
    Cullen, G.
    Doherty, G.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S254 - S254
  • [32] Does Failure to Respond to One Anti-TNF Agent in Ulcerative Colitis Predict Treatment Failure With Other Anti-TNF Agents
    AlAlawi, Fatema
    Keegan, Denise
    Byrne, Kathryn
    Mulcahy, Hugh
    Cullen, Garret
    Doherty, Glen A.
    GASTROENTEROLOGY, 2015, 148 (04) : S266 - S267
  • [33] MUCOSAL HEALING WITH A SECOND ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS AFTER THE FAILURE OF THE PREVIOUS ANTI-TNF TREATMENT
    Papa, A.
    Pugliese, D.
    De Vitis, I.
    D'Aversa, F.
    Landi, R.
    Felice, C.
    Guidi, L.
    Armuzzi, A.
    Rapaccini, G. L.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E203 - E203
  • [34] Anti-TNFα monoclonal antibodies (infliximab) and tuberculosis:: three cases.
    Roth, S
    Delmont, E
    Heudier, P
    Kaphan, R
    Cua, E
    Castela, J
    Verdier, JM
    Chichmanian, RM
    Fuzibet, JG
    REVUE DE MEDECINE INTERNE, 2002, 23 (03): : 312 - 316
  • [35] Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn's Disease
    Kwak, Min Seob
    Cha, Jae Myung
    Jeon, Jung Won
    Yoon, Jin Young
    Park, Su Bee
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2022, 13 (02)
  • [36] Efficacy of Anti-TNF Antibodies in the Treatment of Pouchitis: A Report of 3 Cases
    Kataria, Archish
    Randall, Charles W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S829 - S829
  • [37] What is the optimal dose of thiopurinic drugs (azatioprine) in patients with inflammatory bowel disease under treatment combined with anti-TNFα (infliximab/adalimumab)?
    Lucas Ramos, J.
    Suarez Ferrer, C.
    Sanchez Azofra, M.
    Poza Cordon, J.
    Martin Arranz, E.
    Martin Arranz, M. D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S356 - S356
  • [38] Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis
    Bito, T.
    Nishikawa, R.
    Hatakeyama, M.
    Kikusawa, A.
    Kanki, H.
    Nagai, H.
    Sarayama, Y.
    Ikeda, T.
    Yoshizaki, H.
    Seto, H.
    Adachi, A.
    Horikawa, T.
    Oka, M.
    Nishigori, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (04) : 922 - 929
  • [39] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S427 - S427
  • [40] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
12345